Guanhao Biotech Co.,Ltd.

Status: Publicly traded

Direct answer

Guanhao Biotech Co.,Ltd. is publicly traded on SHZ under the ticker 300238.SZ.

Guanhao Biotech Co.,Ltd. is a Chinese enterprise dedicated to the research, production, and marketing of regenerative medicine solutions. Its product portfolio encompasses NormalGEN, a biological dura repair patch crafted from animal tissue, and GrandNeuro, an artificial alternative for dura restoration. For broader surgical applications, the company offers ThormalGEN, another biological surgical patch also derived...

Can you invest in Guanhao Biotech Co.,Ltd.?

Yes. Guanhao Biotech Co.,Ltd. trades publicly on SHZ as 300238.SZ.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Guanhao Biotech Co.,Ltd.

Detailed equity research is provided by MarketSnap.